LexDanaLexDanabeta
Inventor

Vesselina COOKE

Inventor
US

Overview

5→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
PatentTitleYear
12,208,097Protein kinase C inhibitors for treatment of uveal melanoma202512,036,227Combination therapy202412,011,449Therapeutic combinations comprising a c-RAF inhibitor202411,413,284Protein kinase C inhibitors for treatment of uveal melanoma202211,266,653Combination therapy2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to NOVARTIS AG (5)· patent assignee history
2022–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVARTIS AG52022–2025
Locations
LocationPatentsSpan
US52022–2025